Genomind
Genomind is a leader in precision medicine for mental health, dedicated to helping healthcare providers and patients make better prescribing decisions by leveraging genetic, lifestyle, and environmental data. Their mission is to personalize mental health treatment and improve outcomes for individuals, providers, and healthcare systems. Genomind supports a wide range of stakeholders, including individuals, providers, long-term care facilities, ACOs, employers, health plans, and international partners. Through innovative pharmacogenetic testing, precision medicine software, consultative services, and educational resources, Genomind aims to advance mental health care and empower both patients and professionals.
Industries
Nr. of Employees
medium (51-250)
Genomind
2200 Renaissance Blvd Ste 100, King of Prussia, PA 19406
Awards
Funding Opportunity: 25-07-Pharmacogenomics "Pharmacogenomics (PGx) Testing for Military Readiness Pilot"
Implementing and Assessing Pharmacogenetic Testing for U.S. Active-Duty Service Members
Funding (ceiling)
$2,008,801.95
Award Year
2025
Patents
Products
Clinical pharmacogenetic testing service
Clinical genetic test designed to identify variants relevant to medication response to inform medication selection and dosing.
Gene–drug interaction decision support software
Software platform that identifies gene–drug and drug–drug interaction risks and provides actionable medication recommendations integrated into clinical workflows.
Patient-facing genetic test report
Consumer-oriented report summarizing genetic test results and implications for medication in an accessible format to support patient understanding and shared decision-making.
Clinical pharmacogenetic testing service
Clinical genetic test designed to identify variants relevant to medication response to inform medication selection and dosing.
Gene–drug interaction decision support software
Software platform that identifies gene–drug and drug–drug interaction risks and provides actionable medication recommendations integrated into clinical workflows.
Patient-facing genetic test report
Consumer-oriented report summarizing genetic test results and implications for medication in an accessible format to support patient understanding and shared decision-making.
Expertise Areas
- Pharmacogenomic testing and interpretation
- Clinical decision support for medication management
- EHR interoperability and clinical integration
- Population health analytics for medication safety
Key Technologies
- Pharmacogenomics
- Clinical decision support systems (CDSS)
- EHR integration and interoperability
- HLA genotyping
Key People
News & Updates
An article discussing pharmacotherapy for generalized anxiety disorder and how pharmacogenetic testing can help personalize treatment.
A snapshot of how Americans treat their mental health conditions and the associated costs.
Dr. Bruce Kehr explains the benefits of genetic testing in psychiatry and why he recommends it for his patients.
A guide to meditation for improving focus and reducing stress, anxiety, and depression.
Dr. Christopher Bojrab discusses the mental health challenges faced by athletes and the benefits of Genomind’s genetic test, Genecept Assay.
An overview of medication options for anxiety and how to determine which one may be best for you.
An article discussing pharmacotherapy for generalized anxiety disorder and how pharmacogenetic testing can help personalize treatment.
A snapshot of how Americans treat their mental health conditions and the associated costs.
Dr. Bruce Kehr explains the benefits of genetic testing in psychiatry and why he recommends it for his patients.
A guide to meditation for improving focus and reducing stress, anxiety, and depression.
Dr. Christopher Bojrab discusses the mental health challenges faced by athletes and the benefits of Genomind’s genetic test, Genecept Assay.
An overview of medication options for anxiety and how to determine which one may be best for you.